Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

18/10/2017 The Sixth Ideas Generation Program Sponsored by the Barcelona Synchrotron Park Has Begun 12/10/2017 Barcelona Synchrotron Park's commitment to Biodiversity 02/10/2017 8 Congresses at the same time: it’s the Barcelona Industry Week! 26/09/2017 50th anniversary: congratulations UAB! 21/09/2017 More than 7,000 foreign companies in Catalonia 13/09/2017 How ALBA Synchrotron Works
14 15 16 17 18 19 20 21 22 23 24